Literature DB >> 17098290

P300 is enhanced in responders to vagus nerve stimulation for treatment of major depressive disorder.

A H Neuhaus1, A Luborzewski, J Rentzsch, E L Brakemeier, C Opgen-Rhein, J Gallinat, M Bajbouj.   

Abstract

BACKGROUND: Vagus nerve stimulation (VNS) is a new therapy option for treatment of otherwise therapy-refractory major depressive disorder. However, the mechanism of central nervous action is poorly understood. Electroencephalographic (EEG) studies may be of interest since chronic peripheral current application to the vagus nerve may exert lasting neurophysiologically detectable effects on central electrical activity. In an exploratory study, we investigated the effects of VNS on auditory event-related potentials (ERP).
METHODS: Thirteen depressive patients (mean Hamilton depression score (HAMD) at baseline=24.2) receiving VNS were investigated prior to implantation and 10 weeks after standard cycling VNS. Stimulation intensity was 0.94+/-0.46 mA, pulse width 0.250 mus, and frequency 20 Hz. 1 h prior to follow-up investigation, VNS was turned off. Auditory ERP were elicited using a standard auditory oddball paradigm and were recorded with 29-channel EEG.
RESULTS: Post VNS, grand averages of the auditory ERP did not show significant differences as compared to baseline recording. However, differential effects were found when separating ERP of responders (N=5, mean HAMD post VNS=8.8) and non-responders (N=8, mean HAMD post VNS=22.4). In VNS responders only, P300 at midline electrodes Fz and Cz was significantly increased and correlated with HAMD scores.
CONCLUSION: Auditory ERP seem to provide a useful tool for investigating VNS-induced changes concerning information processing in major depressive disorder. In our sample, enhancement of P300 distinguished VNS responders from non-responders 10 weeks after therapy onset. Our findings may be relevant for the understanding of both neurophysiological mechanism of action of VNS and pathophysiology of depression.

Entities:  

Mesh:

Year:  2006        PMID: 17098290     DOI: 10.1016/j.jad.2006.10.005

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  7 in total

Review 1.  Multimodal approaches to define network oscillations in depression.

Authors:  Otis Lkuwamy Smart; Vineet Ravi Tiruvadi; Helen S Mayberg
Journal:  Biol Psychiatry       Date:  2015-01-28       Impact factor: 13.382

Review 2.  Therapeutic Efficacy of Neurostimulation for Depression: Techniques, Current Modalities, and Future Challenges.

Authors:  Hafsah Akhtar; Faiza Bukhari; Misbah Nazir; Muhammad Nabeel Anwar; Adeeb Shahzad
Journal:  Neurosci Bull       Date:  2016-01-19       Impact factor: 5.203

3.  The P3 event-related potential is a biomarker for the efficacy of vagus nerve stimulation in patients with epilepsy.

Authors:  Leen De Taeye; Kristl Vonck; Marlies van Bochove; Paul Boon; Dirk Van Roost; Lies Mollet; Alfred Meurs; Veerle De Herdt; Evelien Carrette; Ine Dauwe; Stefanie Gadeyne; Pieter van Mierlo; Tom Verguts; Robrecht Raedt
Journal:  Neurotherapeutics       Date:  2014-07       Impact factor: 7.620

Review 4.  Rapid Effects of Vagus Nerve Stimulation on Sensory Processing Through Activation of Neuromodulatory Systems.

Authors:  Charles Rodenkirch; Jason B Carmel; Qi Wang
Journal:  Front Neurosci       Date:  2022-07-05       Impact factor: 5.152

5.  Vagus nerve stimulation for treatment-resistant mood disorders: a long-term naturalistic study.

Authors:  Umberto Albert; Giuseppe Maina; Andrea Aguglia; Alberto Vitalucci; Filippo Bogetto; Chiara Fronda; Alessandro Ducati; Michele Lanotte
Journal:  BMC Psychiatry       Date:  2015-03-31       Impact factor: 3.630

6.  Effects of Transcutaneous Vagus Nerve Stimulation (tVNS) on the P300 and Alpha-Amylase Level: A Pilot Study.

Authors:  Carlos Ventura-Bort; Janine Wirkner; Hannah Genheimer; Julia Wendt; Alfons O Hamm; Mathias Weymar
Journal:  Front Hum Neurosci       Date:  2018-06-21       Impact factor: 3.169

Review 7.  International Consensus Based Review and Recommendations for Minimum Reporting Standards in Research on Transcutaneous Vagus Nerve Stimulation (Version 2020).

Authors:  Adam D Farmer; Adam Strzelczyk; Alessandra Finisguerra; Alexander V Gourine; Alireza Gharabaghi; Alkomiet Hasan; Andreas M Burger; Andrés M Jaramillo; Ann Mertens; Arshad Majid; Bart Verkuil; Bashar W Badran; Carlos Ventura-Bort; Charly Gaul; Christian Beste; Christopher M Warren; Daniel S Quintana; Dorothea Hämmerer; Elena Freri; Eleni Frangos; Eleonora Tobaldini; Eugenijus Kaniusas; Felix Rosenow; Fioravante Capone; Fivos Panetsos; Gareth L Ackland; Gaurav Kaithwas; Georgia H O'Leary; Hannah Genheimer; Heidi I L Jacobs; Ilse Van Diest; Jean Schoenen; Jessica Redgrave; Jiliang Fang; Jim Deuchars; Jozsef C Széles; Julian F Thayer; Kaushik More; Kristl Vonck; Laura Steenbergen; Lauro C Vianna; Lisa M McTeague; Mareike Ludwig; Maria G Veldhuizen; Marijke De Couck; Marina Casazza; Marius Keute; Marom Bikson; Marta Andreatta; Martina D'Agostini; Mathias Weymar; Matthew Betts; Matthias Prigge; Michael Kaess; Michael Roden; Michelle Thai; Nathaniel M Schuster; Nicola Montano; Niels Hansen; Nils B Kroemer; Peijing Rong; Rico Fischer; Robert H Howland; Roberta Sclocco; Roberta Sellaro; Ronald G Garcia; Sebastian Bauer; Sofiya Gancheva; Stavros Stavrakis; Stefan Kampusch; Susan A Deuchars; Sven Wehner; Sylvain Laborde; Taras Usichenko; Thomas Polak; Tino Zaehle; Uirassu Borges; Vanessa Teckentrup; Vera K Jandackova; Vitaly Napadow; Julian Koenig
Journal:  Front Hum Neurosci       Date:  2021-03-23       Impact factor: 3.169

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.